ArticleCancer research and treatment2017

Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma.

Yongjun Cha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.